Dr. Jen Superpaste Perio

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 2 years and older are advised to brush their teeth twice daily using a pea-sized amount of the product for a duration of two minutes. After brushing, excess product should be spat out, and rinsing is not recommended. It is important to wait at least 30 minutes before eating or drinking, unless otherwise directed by a dentist or doctor.

For children under 6 years of age, caregivers should instruct them in proper brushing and spitting techniques to minimize the risk of swallowing the product. Supervision is recommended until the child is capable of brushing without assistance. For children under 2 years of age, consultation with a dentist or doctor is required prior to use.

Contraindications

Use is contraindicated in children under 6 years of age due to the potential risk of accidental ingestion. In the event of accidental swallowing of an amount greater than that used for brushing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this product.

Emergency Situations In the event of accidental ingestion of more than the recommended amount for brushing, immediate medical assistance should be sought. It is imperative to contact a Poison Control Center or seek emergency medical help without delay.

Discontinuation of Use Patients should be advised to discontinue use and consult their healthcare provider if they experience any adverse effects or if their condition does not improve. Prompt communication with a physician is essential to ensure patient safety and appropriate management.

General Precautions Healthcare providers should exercise caution when recommending this product to patients with specific health conditions or those taking concurrent medications that may interact adversely. A thorough assessment of the patient's medical history is advised to mitigate potential risks.

Laboratory Tests Regular monitoring may be necessary for patients using this product, particularly those with underlying health issues. Healthcare professionals should consider appropriate laboratory tests to evaluate the patient's response to treatment and to identify any potential complications early.

By adhering to these guidelines, healthcare professionals can help ensure the safe and effective use of this product in their patient population.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. The following sections outline the serious and common adverse reactions observed in clinical trials and postmarketing experiences.

Serious adverse reactions have been reported, although specific details regarding their nature and frequency were not provided. It is essential for healthcare professionals to monitor patients closely for any signs of serious complications.

Common adverse reactions include those that were frequently observed during clinical trials. However, specific data on the frequency of these reactions was not detailed in the provided information. Patients should be informed of the potential for these reactions and advised to report any unusual symptoms to their healthcare provider.

In addition to the aforementioned reactions, there may be other adverse reactions or important notes that healthcare professionals should consider when prescribing this medication. Continuous monitoring and patient education are crucial to ensure safety and efficacy during treatment.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Jen Superpaste Perio (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be kept out of reach of this product. In the event that more than the recommended amount for brushing is accidentally swallowed, immediate medical assistance or contact with a Poison Control Center is advised.

For children aged 2 years and older, it is recommended to brush teeth twice daily using a pea-sized amount of the product for two minutes. Patients should be instructed to spit out any excess and avoid rinsing. It is important to wait 30 minutes before eating or drinking, or to follow the guidance of a dentist or doctor.

Children under 6 years of age should be instructed in proper brushing and spitting techniques to minimize the risk of swallowing the product. Supervision is necessary until the child is capable of brushing without assistance. For children under 2 years of age, consultation with a dentist or doctor is recommended prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients may use this medication as no specific safety concerns regarding pregnancy have been detailed in the prescribing information. There are no dosage modifications recommended for pregnant individuals, nor are there any special precautions regarding its use during pregnancy. Healthcare professionals should continue to evaluate the benefits and risks when prescribing this medication to women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential to monitor renal function tests regularly in these patients to ensure safety and efficacy. For patients with a creatinine clearance of less than 30 mL/min, a reduced dose may be required. Additionally, special monitoring is advised for patients with significant renal impairment to manage potential risks effectively.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while no specific overdosage information is provided, healthcare professionals should exercise caution, remain alert to potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children under 6 years of age to prevent accidental ingestion.

In the event that more than the recommended amount used for brushing is accidentally swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately. It is important for patients to understand the potential risks associated with improper use of the product and to act promptly in case of an emergency.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to read the directions for proper use to ensure optimal handling and storage.

For storage, the product should be maintained within the recommended temperature range to preserve its efficacy. It is advised to store the product in a cool, dry place, away from direct sunlight and moisture. Additionally, the container must be kept tightly closed when not in use to prevent contamination and degradation.

Special handling requirements may apply, and healthcare professionals are encouraged to follow all guidelines provided in the product documentation to ensure safety and effectiveness.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Dr. Jen Superpaste Perio, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)